$NWFL
NORWOOD FINANCIAL CORP

2024 Q4 Form 10-Q Financial Statement

#000156276224000265 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $1.874M
YoY Change -2.5%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $351.0K
YoY Change 0.29%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $4.850M
YoY Change -6.5%
Income Tax $1.006M
% Of Pretax Income 20.74%
Net Earnings $3.844M
YoY Change -6.68%
Net Earnings / Revenue 205.12%
Basic Earnings Per Share $0.48
Diluted Earnings Per Share $0.48
COMMON SHARES
Basic Shares Outstanding 8.092M 8.085M
Diluted Shares Outstanding 8.052M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $82.88M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $18.50M
YoY Change 7.24%
Goodwill $29.27M
YoY Change 0.0%
Intangibles $167.0K
YoY Change -30.42%
Long-Term Investments
YoY Change
Other Assets $18.82M
YoY Change -26.49%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $2.280B
YoY Change 4.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.69M
YoY Change 47.53%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $52.45M
YoY Change -49.51%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $65.14M
YoY Change -54.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $18.75M
YoY Change 1.33%
Total Long-Term Liabilities $18.75M
YoY Change 1.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $65.14M
Total Long-Term Liabilities $18.75M
Total Liabilities $2.084B
YoY Change 3.41%
SHAREHOLDERS EQUITY
Retained Earnings $140.5M
YoY Change 2.28%
Common Stock $831.0K
YoY Change 0.24%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.969M
YoY Change 0.2%
Treasury Stock Shares
Shareholders Equity $195.7M
YoY Change
Total Liabilities & Shareholders Equity $2.280B
YoY Change 4.58%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $3.844M
YoY Change -6.68%
Depreciation, Depletion And Amortization $351.0K
YoY Change 0.29%
Cash From Operating Activities $4.645M
YoY Change -32.49%
INVESTING ACTIVITIES
Capital Expenditures $573.0K
YoY Change 149.13%
Acquisitions
YoY Change
Other Investing Activities -$19.33M
YoY Change -29.64%
Cash From Investing Activities -$19.90M
YoY Change -28.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 28.74M
YoY Change -31.36%
NET CHANGE
Cash From Operating Activities 4.645M
Cash From Investing Activities -19.90M
Cash From Financing Activities 28.74M
Net Change In Cash 13.49M
YoY Change -35.94%
FREE CASH FLOW
Cash From Operating Activities $4.645M
Capital Expenditures $573.0K
Free Cash Flow $4.072M
YoY Change -38.77%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Central Index Key
EntityCentralIndexKey
0001013272
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q4 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherAssets
CY2024Q3 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherAssets
CY2023Q4 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherLiabilities
CY2024Q3 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherLiabilities
CY2023Q4 us-gaap Investment Variable Interest Rate Type Extensible Enumeration
InvestmentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember
CY2024Q3 us-gaap Investment Variable Interest Rate Type Extensible Enumeration
InvestmentVariableInterestRateTypeExtensibleEnumeration
http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-28364
dei Entity Registrant Name
EntityRegistrantName
Norwood Financial Corp
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
PA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-2828306
dei Entity Address Address Line1
EntityAddressAddressLine1
717 Main Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Honesdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
18431
dei City Area Code
CityAreaCode
570
dei Local Phone Number
LocalPhoneNumber
253-1455
dei Security12b Title
Security12bTitle
Common Stock, par value $0.10 per share
dei Trading Symbol
TradingSymbol
NWFL
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8091755
CY2024Q3 us-gaap Cash And Due From Banks
CashAndDueFromBanks
47072000
CY2023Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
28533000
CY2024Q3 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
35808000
CY2023Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
37587000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82880000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66120000
CY2023Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2024Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
396891000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
406259000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
18699000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
18968000
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1656440000
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1584650000
CY2024Q3 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
6329000
CY2023Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
7318000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
18503000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17838000
CY2024Q3 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
46382000
CY2023Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
46439000
CY2024Q3 us-gaap Interest Receivable
InterestReceivable
8062000
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
8123000
CY2023Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
97000
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
18818000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
21353000
CY2024Q3 us-gaap Goodwill
Goodwill
29266000
CY2023Q4 us-gaap Goodwill
Goodwill
29266000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
167000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
221000
CY2024Q3 us-gaap Other Assets
OtherAssets
16013000
CY2023Q4 us-gaap Other Assets
OtherAssets
13395000
CY2024Q3 us-gaap Assets
Assets
2279751000
CY2023Q4 us-gaap Assets
Assets
2201079000
CY2024Q3 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
420967000
CY2023Q4 us-gaap Noninterest Bearing Deposit Liabilities Domestic
NoninterestBearingDepositLiabilitiesDomestic
399545000
CY2024Q3 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
1434284000
CY2023Q4 us-gaap Interest Bearing Deposit Liabilities Domestic
InterestBearingDepositLiabilitiesDomestic
1395614000
CY2024Q3 us-gaap Deposits
Deposits
1855251000
CY2023Q4 us-gaap Deposits
Deposits
1795159000
CY2024Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
52453000
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
74076000
CY2024Q3 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
144959000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
124236000
CY2024Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
12688000
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
10510000
CY2024Q3 us-gaap Other Liabilities
OtherLiabilities
18746000
CY2023Q4 us-gaap Other Liabilities
OtherLiabilities
16028000
CY2024Q3 us-gaap Liabilities
Liabilities
2084097000
CY2023Q4 us-gaap Liabilities
Liabilities
2020009000
CY2023Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2024Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8311851
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8310847
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
831000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
831000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
98330000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
97700000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
140489000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
135284000
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
221140
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
200690
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
5969000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5397000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-38027000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-47348000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
195654000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
181070000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2279751000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2201079000
CY2024Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
25464000
CY2023Q3 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
22021000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
73266000
us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
61881000
CY2024Q3 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
2526000
CY2023Q3 us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
2433000
us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
7635000
us-gaap Interest And Dividend Income Securities
InterestAndDividendIncomeSecurities
7418000
CY2024Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
497000
CY2023Q3 us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
54000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
2194000
us-gaap Other Interest And Dividend Income
OtherInterestAndDividendIncome
156000
CY2024Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
28487000
CY2023Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
24508000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
83095000
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
69455000
CY2024Q3 us-gaap Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
10553000
CY2023Q3 us-gaap Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
7017000
us-gaap Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
31349000
us-gaap Interest Expense Domestic Deposits
InterestExpenseDomesticDeposits
17119000
CY2024Q3 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
323000
CY2023Q3 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
1126000
us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
1015000
us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
2702000
CY2024Q3 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
1680000
CY2023Q3 us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
1326000
us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
5165000
us-gaap Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term
InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm
2860000
CY2024Q3 us-gaap Interest Expense Operating
InterestExpenseOperating
12556000
CY2023Q3 us-gaap Interest Expense Operating
InterestExpenseOperating
9469000
us-gaap Interest Expense Operating
InterestExpenseOperating
37529000
us-gaap Interest Expense Operating
InterestExpenseOperating
22681000
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
15931000
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
15039000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
45566000
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
46774000
CY2024Q3 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1345000
CY2023Q3 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
882000
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1069000
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-568000
CY2024Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
14586000
CY2023Q3 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
14157000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
44497000
us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
47342000
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-209000
CY2024Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
103000
CY2023Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
18000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
145000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
27000
CY2023Q3 nwfl Gain Loss On Sale Of Foreclosed Real Estate
GainLossOnSaleOfForeclosedRealEstate
13000
nwfl Gain Loss On Sale Of Foreclosed Real Estate
GainLossOnSaleOfForeclosedRealEstate
32000
nwfl Gain Loss On Sale Of Foreclosed Real Estate
GainLossOnSaleOfForeclosedRealEstate
13000
CY2024Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
261000
CY2023Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
328000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
781000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
770000
CY2024Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
158000
CY2023Q3 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
174000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
467000
us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
520000
CY2024Q3 us-gaap Noninterest Income
NoninterestIncome
2295000
CY2023Q3 us-gaap Noninterest Income
NoninterestIncome
2306000
us-gaap Noninterest Income
NoninterestIncome
6508000
us-gaap Noninterest Income
NoninterestIncome
6001000
CY2024Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6239000
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
6083000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
18328000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
17893000
CY2024Q3 us-gaap Occupancy Net
OccupancyNet
1269000
CY2023Q3 us-gaap Occupancy Net
OccupancyNet
1242000
us-gaap Occupancy Net
OccupancyNet
3758000
us-gaap Occupancy Net
OccupancyNet
3818000
CY2024Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1162000
CY2023Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
876000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
3208000
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2465000
CY2024Q3 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
179000
CY2023Q3 us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
167000
us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
452000
us-gaap Taxes Excluding Income And Excise Taxes
TaxesExcludingIncomeAndExciseTaxes
490000
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
576000
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
524000
us-gaap Professional Fees
ProfessionalFees
1669000
us-gaap Professional Fees
ProfessionalFees
1132000
CY2024Q3 nwfl Federal Deposit Insurance Corporation Premium Expense Income
FederalDepositInsuranceCorporationPremiumExpenseIncome
339000
CY2023Q3 nwfl Federal Deposit Insurance Corporation Premium Expense Income
FederalDepositInsuranceCorporationPremiumExpenseIncome
254000
nwfl Federal Deposit Insurance Corporation Premium Expense Income
FederalDepositInsuranceCorporationPremiumExpenseIncome
1009000
nwfl Federal Deposit Insurance Corporation Premium Expense Income
FederalDepositInsuranceCorporationPremiumExpenseIncome
699000
CY2024Q3 nwfl Foreclosed Real Estate Expense Income
ForeclosedRealEstateExpenseIncome
9000
CY2023Q3 nwfl Foreclosed Real Estate Expense Income
ForeclosedRealEstateExpenseIncome
9000
nwfl Foreclosed Real Estate Expense Income
ForeclosedRealEstateExpenseIncome
45000
nwfl Foreclosed Real Estate Expense Income
ForeclosedRealEstateExpenseIncome
112000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
54000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
66000
CY2024Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2242000
CY2023Q3 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2101000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
6683000
us-gaap Other Noninterest Expense
OtherNoninterestExpense
5974000
CY2024Q3 us-gaap Noninterest Expense
NoninterestExpense
12031000
CY2023Q3 us-gaap Noninterest Expense
NoninterestExpense
11276000
us-gaap Noninterest Expense
NoninterestExpense
35206000
us-gaap Noninterest Expense
NoninterestExpense
32649000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4850000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5187000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
15799000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
20694000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1006000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1068000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3308000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4289000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
3844000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
4119000
us-gaap Net Income Loss
NetIncomeLoss
12491000
us-gaap Net Income Loss
NetIncomeLoss
16405000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.51
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.03
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.51
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.55
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.03
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
3844000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
4119000
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
14928000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-13586000
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
3136000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-2853000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11792000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10733000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15636000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6614000
us-gaap Net Income Loss
NetIncomeLoss
12491000
us-gaap Net Income Loss
NetIncomeLoss
16405000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
11799000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-9867000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
2478000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-2073000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
-209000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
-44000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9321000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7629000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21812000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8776000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
181070000
us-gaap Net Income Loss
NetIncomeLoss
12491000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9321000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.90
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
7286000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
676000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
280000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
193000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
261000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
195654000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
167085000
us-gaap Net Income Loss
NetIncomeLoss
16405000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7629000
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.87
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
7051000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3077000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
326000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
367000
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
287000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
164702000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
182187000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
3844000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
11792000
CY2024Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.30
CY2024Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2425000
CY2024Q3 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
226000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
203000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
193000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
86000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
195654000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
173424000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
4119000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10733000
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.29
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
2339000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
102000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
33000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
96000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
164702000
us-gaap Net Income Loss
NetIncomeLoss
12491000
us-gaap Net Income Loss
NetIncomeLoss
16405000
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
1069000
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-568000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
995000
us-gaap Depreciation Nonproduction
DepreciationNonproduction
1043000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
54000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
66000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
57000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-33000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-442000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-694000
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-209000
us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
781000
us-gaap Life Insurance Corporate Or Bank Owned Change In Value
LifeInsuranceCorporateOrBankOwnedChangeInValue
770000
nwfl Gain Loss On Sales And Write Downs Of Fixed Assets And Foreclosed Real Estate Owned Net
GainLossOnSalesAndWriteDownsOfFixedAssetsAndForeclosedRealEstateOwnedNet
32000
nwfl Gain Loss On Sales And Write Downs Of Fixed Assets And Foreclosed Real Estate Owned Net
GainLossOnSalesAndWriteDownsOfFixedAssetsAndForeclosedRealEstateOwnedNet
-163000
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-474000
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-428000
us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
145000
us-gaap Gain Loss On Sale Of Mortgage Loans
GainLossOnSaleOfMortgageLoans
27000
us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
6490000
us-gaap Increase Decrease In Mortgage Loans Held For Sale
IncreaseDecreaseInMortgageLoansHeldForSale
3310000
us-gaap Increase Decrease In Loans Held For Sale
IncreaseDecreaseInLoansHeldForSale
-6635000
us-gaap Increase Decrease In Loans Held For Sale
IncreaseDecreaseInLoansHeldForSale
-3337000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
261000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
287000
us-gaap Restricted Stock Expense
RestrictedStockExpense
280000
us-gaap Restricted Stock Expense
RestrictedStockExpense
326000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-61000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
842000
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
2178000
us-gaap Increase Decrease In Operating Liabilities
IncreaseDecreaseInOperatingLiabilities
5952000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-452000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
251000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
18001000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23109000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
3345000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
44714000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
24523000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
23990000
us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
7961000
us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
15242000
us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
8950000
us-gaap Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
11817000
us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
73658000
us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
140442000
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
838000
us-gaap Proceeds From Life Insurance Policies
ProceedsFromLifeInsurancePolicies
437000
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
2500000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1660000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
496000
us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
109000
us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
305000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-52658000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-118252000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
60092000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
19097000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-21623000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
10666000
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
39277000
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
57553000
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
60000000
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
155000000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
193000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
367000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
676000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3077000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7292000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7077000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
51417000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
117423000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
16760000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
22280000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66120000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31866000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82880000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
54146000
us-gaap Interest Paid Net
InterestPaidNet
35351000
us-gaap Interest Paid Net
InterestPaidNet
16729000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1682000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4777000
us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
1502000
us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
1451000
us-gaap Dividends Cash
DividendsCash
2427000
us-gaap Dividends Cash
DividendsCash
2340000
nwfl Right Of Use Asset
RightOfUseAsset
431000
us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
431000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1874000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1922000
CY2024Q3 nwfl Loan Servicing Fees
LoanServicingFees
57000
CY2023Q3 nwfl Loan Servicing Fees
LoanServicingFees
38000
CY2024Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
103000
CY2023Q3 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
18000
CY2024Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
261000
CY2023Q3 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
328000
CY2024Q3 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
421000
CY2023Q3 us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
384000
CY2024Q3 us-gaap Noninterest Income
NoninterestIncome
2295000
CY2023Q3 us-gaap Noninterest Income
NoninterestIncome
2306000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5466000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5325000
us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
-209000
nwfl Loan Servicing Fees
LoanServicingFees
116000
nwfl Loan Servicing Fees
LoanServicingFees
88000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
145000
us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
27000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
781000
us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
770000
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
1042000
us-gaap Revenue Not From Contract With Customer
RevenueNotFromContractWithCustomer
676000
us-gaap Noninterest Income
NoninterestIncome
6508000
us-gaap Noninterest Income
NoninterestIncome
6001000
CY2024Q3 nwfl Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
8091000
CY2023Q3 nwfl Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
8069000
nwfl Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
8099000
nwfl Weighted Average Shares Outstanding
WeightedAverageSharesOutstanding
8115000
CY2024Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
45000
CY2023Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
42000
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
45000
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
43000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8046000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8027000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8054000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8072000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8046000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8027000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8054000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8072000
CY2024Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6000
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8052000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8033000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8060000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8078000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
135350
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
135350
CY2024Q3 us-gaap Share Price
SharePrice
27.58
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
166100
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
166100
CY2023Q3 us-gaap Share Price
SharePrice
25.76
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
261000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
287000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
215725
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.81
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
759000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
8680
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
22.22
nwfl Weighted Average Remaining Contractual Term Options Exercised During Period
WeightedAverageRemainingContractualTermOptionsExercisedDuringPeriod
P3Y3M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
7500
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
30.93
nwfl Weighted Average Remaining Contractual Term Options Forfeited During Period
WeightedAverageRemainingContractualTermOptionsForfeitedDuringPeriod
P8Y1M6D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
199545
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.32
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y2M12D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
122000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
164045
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
30.20
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y6M
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
122000
CY2024Q3 us-gaap Share Price
SharePrice
27.58
CY2023Q4 us-gaap Share Price
SharePrice
32.91
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
45966
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
29.90
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
44460
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.12
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1004
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
24.90
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1200
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
25.71
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
3000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
25.71
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
4350
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
29.98
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
41420
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
29.72
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
41460
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.44
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
41420
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
970000
nwfl Non Vested Restricted Stock Recognition Period
NonVestedRestrictedStockRecognitionPeriod
P4Y3M
CY2024Q3 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
261317000
CY2023Q3 us-gaap Fair Value Disclosure Offbalance Sheet Risks Amount Liability
FairValueDisclosureOffbalanceSheetRisksAmountLiability
264007000
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
3
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions
327
CY2023Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2024Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
16155000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
16055000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
42178000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
39916000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
81379000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
70130000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
72198000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
64037000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
211910000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
190138000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
233741000
CY2024Q3 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
206753000
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
445651000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
396891000
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
4000
us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
213000
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
-209000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
3345000
CY2024Q3 us-gaap Debt Securities
DebtSecurities
360529000
CY2023Q4 us-gaap Debt Securities
DebtSecurities
344204000
CY2024Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
1675579000
CY2024Q3 nwfl Percent Of Loans
PercentOfLoans
1.000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1603877000
CY2023Q4 nwfl Percent Of Loans
PercentOfLoans
1.000
CY2024Q3 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
440000
CY2023Q4 us-gaap Financing Receivable Deferred Income
FinancingReceivableDeferredIncome
259000
CY2024Q3 nwfl Financing Receivable Net Of Deferred Income
FinancingReceivableNetOfDeferredIncome
1675139000
CY2023Q4 nwfl Financing Receivable Net Of Deferred Income
FinancingReceivableNetOfDeferredIncome
1603618000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
18699000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
18968000
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1656440000
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1584650000
CY2024Q3 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
0
CY2023Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
97000
CY2024Q3 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
7888000
CY2024Q3 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1667691000
CY2024Q3 us-gaap Notes Receivable Gross
NotesReceivableGross
1675579000
CY2023Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
7622000
CY2023Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
1596255000
CY2023Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
1603877000
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
18968000
us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
1382000
us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery
225000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
888000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
18699000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
239000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
18460000
CY2024Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
17806000
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
358000
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery
35000
CY2024Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1216000
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
18699000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
16999000
us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
2999000
us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery
102000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-482000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
16086000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
16086000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
17483000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
2384000
CY2023Q3 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery
35000
CY2023Q3 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
952000
CY2023Q3 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
16086000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
888000
CY2024Q3 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
7192000
CY2024Q3 nwfl Financing Receivable Nonaccrual With Allowance
FinancingReceivableNonaccrualWithAllowance
696000
CY2024Q3 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
7888000
CY2024Q3 nwfl Financing Receivable Nonperforming Loans
FinancingReceivableNonperformingLoans
7888000
CY2023Q4 us-gaap Financing Receivable Nonaccrual No Allowance
FinancingReceivableNonaccrualNoAllowance
7069000
CY2023Q4 nwfl Financing Receivable Nonaccrual With Allowance
FinancingReceivableNonaccrualWithAllowance
553000
CY2023Q4 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
7622000
CY2023Q4 nwfl Financing Receivable Nonperforming Loans
FinancingReceivableNonperformingLoans
7622000
CY2023 us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
524000
us-gaap Financing Receivable Modifications Post Modification Recorded Investment2
FinancingReceivableModificationsPostModificationRecordedInvestment2
524000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
82880000
CY2024Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
82880000
CY2024Q3 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1656440000
CY2024Q3 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
1627200000
CY2024Q3 us-gaap Servicing Asset
ServicingAsset
193000
CY2024Q3 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
529000
CY2024Q3 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
6329000
CY2024Q3 us-gaap Investment In Federal Home Loan Bank Stock Fair Value Disclosure
InvestmentInFederalHomeLoanBankStockFairValueDisclosure
6329000
CY2024Q3 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
46382000
CY2024Q3 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
46382000
CY2024Q3 us-gaap Interest Receivable
InterestReceivable
8062000
CY2024Q3 nwfl Accrued Interest Receivable Fair Value Disclosure
AccruedInterestReceivableFairValueDisclosure
8062000
CY2024Q3 us-gaap Deposits
Deposits
1855251000
CY2024Q3 us-gaap Deposits Fair Value Disclosure
DepositsFairValueDisclosure
1799780000
CY2024Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
52453000
CY2024Q3 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
52453000
CY2024Q3 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
144959000
CY2024Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
145465000
CY2024Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
12688000
CY2024Q3 nwfl Accrued Interest Payable Fair Value Disclosure
AccruedInterestPayableFairValueDisclosure
12688000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66120000
CY2023Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
66120000
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
1584650000
CY2023Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
1521667000
CY2023Q4 us-gaap Servicing Asset
ServicingAsset
188000
CY2023Q4 us-gaap Servicing Asset At Fair Value Amount
ServicingAssetAtFairValueAmount
506000
CY2023Q4 us-gaap Federal Home Loan Bank Stock
FederalHomeLoanBankStock
7318000
CY2023Q4 us-gaap Investment In Federal Home Loan Bank Stock Fair Value Disclosure
InvestmentInFederalHomeLoanBankStockFairValueDisclosure
7318000
CY2023Q4 us-gaap Bank Owned Life Insurance
BankOwnedLifeInsurance
46439000
CY2023Q4 us-gaap Cash Surrender Value Fair Value Disclosure
CashSurrenderValueFairValueDisclosure
46439000
CY2023Q4 us-gaap Interest Receivable
InterestReceivable
8123000
CY2023Q4 nwfl Accrued Interest Receivable Fair Value Disclosure
AccruedInterestReceivableFairValueDisclosure
8123000
CY2023Q4 us-gaap Deposits
Deposits
1795159000
CY2023Q4 us-gaap Deposits Fair Value Disclosure
DepositsFairValueDisclosure
1800104000
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
74076000
CY2023Q4 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
74076000
CY2023Q4 us-gaap Federal Home Loan Bank Advances Long Term
FederalHomeLoanBankAdvancesLongTerm
124236000
CY2023Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
124058000
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
10510000
CY2023Q4 nwfl Accrued Interest Payable Fair Value Disclosure
AccruedInterestPayableFairValueDisclosure
10510000

Files In Submission

Name View Source Status
0001562762-24-000265-index-headers.html Edgar Link pending
0001562762-24-000265-index.html Edgar Link pending
0001562762-24-000265.txt Edgar Link pending
0001562762-24-000265-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nwfl-20240930.xsd Edgar Link pending
nwfl-20240930x10q.htm Edgar Link pending
nwfl-20240930xex31_1.htm Edgar Link pending
nwfl-20240930xex31_2.htm Edgar Link pending
nwfl-20240930xex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nwfl-20240930_cal.xml Edgar Link unprocessable
nwfl-20240930_def.xml Edgar Link unprocessable
nwfl-20240930_lab.xml Edgar Link unprocessable
nwfl-20240930_pre.xml Edgar Link unprocessable
nwfl-20240930x10q_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending